Dr. McAnally is a pediatric neurologist with subspecialty training in adult and pediatric neuromuscular medicine and additional clinical and translational research training in genetic neuromuscular disorders of childhood at the National Institutes of Health. She specializes in the diagnosis and management of rare and ultra-rare genetic neuromuscular disorders, including Charcot–Marie–Tooth (CMT) disease.
Her research focuses on developing clinical outcome measures and identifying biomarkers to track disease progression and therapeutic response. She has a particular interest in the use of muscle ultrasound to characterize imaging features of genetic neuromuscular disorders as both a diagnostic tool and a biomarker to support therapeutic development. Together with the multidisciplinary team at Cincinnati Children’s, Dr. McAnally is committed to delivering the highest quality evidence-based care while expanding access to emerging therapies for patients with rare neuromuscular diseases.
